BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31063460)

  • 1. Expression of Protein 4.1 Family in Breast Cancer: Database Mining for 4.1 Family Members in Malignancies.
    Feng G; Guo K; Yan Q; Ye Y; Shen M; Ruan S; Qiu S
    Med Sci Monit; 2019 May; 25():3374-3389. PubMed ID: 31063460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexpression of PBX1 and EMP2 as Prognostic Biomarkers in Estrogen Receptor-Negative Breast Cancer via Data Mining.
    Qiu Y; Lu G; Wu Y
    J Comput Biol; 2020 Oct; 27(10):1509-1518. PubMed ID: 32216630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GATA3 and TRPS1 are distinct biomarkers and prognostic factors in breast cancer: database mining for GATA family members in malignancies.
    Lin HY; Zeng D; Liang YK; Wei XL; Chen CF
    Oncotarget; 2017 May; 8(21):34750-34761. PubMed ID: 28423734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCR4 and CXCR3 are two distinct prognostic biomarkers in breast cancer: Database mining for CXCR family members.
    Guo K; Feng G; Yan Q; Sun L; Zhang K; Shen F; Shen M; Ruan S
    Mol Med Rep; 2019 Dec; 20(6):4791-4802. PubMed ID: 31702806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the prognostic significance of solute carrier (SLC) family 39 genes in breast cancer.
    Liu L; Yang J; Wang C
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32744318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative analysis of prognostic value and immune infiltration of spindle and kinetochore-associated family members in breast cancer.
    Ding J; He X; Wang J; Cao G; Chen S; Yuan L; Chen B; Xiong M
    Bioengineered; 2021 Dec; 12(2):10905-10923. PubMed ID: 34845974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
    Wu JR; Zhao Y; Zhou XP; Qin X
    Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CMTM5/7 are biomarkers and prognostic factors in human breast carcinoma.
    Wu J
    Cancer Biomark; 2020; 29(1):89-99. PubMed ID: 32568178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic values of the inhibitor of DNA‑binding family members in breast cancer.
    Zhou XL; Zeng D; Ye YH; Sun SM; Lu XF; Liang WQ; Chen CF; Lin HY
    Oncol Rep; 2018 Oct; 40(4):1897-1906. PubMed ID: 30066902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct prognostic values of ALDH1 isoenzymes in breast cancer.
    Wu S; Xue W; Huang X; Yu X; Luo M; Huang Y; Liu Y; Bi Z; Qiu X; Bai S
    Tumour Biol; 2015 Apr; 36(4):2421-6. PubMed ID: 25582316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics analysis of prognostic significance of COL10A1 in breast cancer.
    Zhang M; Chen H; Wang M; Bai F; Wu K
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32043519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic values of distinct CBX family members in breast cancer.
    Liang YK; Lin HY; Chen CF; Zeng D
    Oncotarget; 2017 Nov; 8(54):92375-92387. PubMed ID: 29190923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enabled homolog shown to be a potential biomarker and prognostic indicator for breast cancer by bioinformatics analysis.
    Li QL; Su YL; Zeng M; Shen WX
    Clin Invest Med; 2019 Jan; 41(4):E186-E195. PubMed ID: 30737978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated analysis identifies TfR1 as a prognostic biomarker which correlates with immune infiltration in breast cancer.
    Chen F; Fan Y; Hou J; Liu B; Zhang B; Shang Y; Chang Y; Cao P; Tan K
    Aging (Albany NY); 2021 Sep; 13(17):21671-21699. PubMed ID: 34518441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of the prognostic value and immune function of chemokine-CXC receptor family members in breast cancer.
    Lyu L; Zheng Y; Hong Y; Wang M; Deng Y; Wu Y; Xu P; Yang S; Wang S; Yao J; Zhang D; Guo Y; Lyu J; Dai Z
    Int Immunopharmacol; 2020 Oct; 87():106797. PubMed ID: 32702599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transcriptional STAT3 is a potential target, whereas transcriptional STAT5A/5B/6 are new biomarkers for prognosis in human breast carcinoma.
    Wu HT; Liu J; Li GW; Shen JX; Huang YT
    Oncotarget; 2017 May; 8(22):36279-36288. PubMed ID: 28422733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat Shock Protein 90 Family Isoforms as Prognostic Biomarkers and Their Correlations with Immune Infiltration in Breast Cancer.
    Lin T; Qiu Y; Peng W; Peng L
    Biomed Res Int; 2020; 2020():2148253. PubMed ID: 33145341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of KN motif and ankyrin repeat domains 1 (KANK1) in invasive breast cancer.
    Kariri YA; Joseph C; Kurozumi S; Toss MS; Alsaleem M; Raafat S; Mongan NP; Aleskandarany MA; Green AR; Rakha EA
    Breast Cancer Res Treat; 2020 Jan; 179(2):349-357. PubMed ID: 31679074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of long non-coding RNA linc-ITGB1 in breast cancer and its influence on prognosis and survival.
    Li WX; Sha RL; Bao JQ; Luan W; Su RL; Sun SR
    Eur Rev Med Pharmacol Sci; 2017 Aug; 21(15):3397-3401. PubMed ID: 28829502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression Profile and Prognostic Values of Mini-Chromosome Maintenance Families (MCMs) in Breast Cancer.
    Cheng L; Tan Z; Huang Z; Pan Y; Zhang W; Wang J
    Med Sci Monit; 2020 Aug; 26():e923673. PubMed ID: 32830194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.